In the first quarter of 2012, Thermo Fisher Scientific Inc. announced to reduce 230 employees and 100 of them were in the analysis technology department, and PerkinElmer laid off 139 staffs in the worldwide. The leading analytical instrument companies are preparing for the uncertain global economic recovery, but most of them transfer the attention to Asia market especially China by the fact of strong demand, such as AB SCIEX had increased 50-60 staffs in China in 2011. In 2011, Thermo Fisher Scientific invested nearly $90.0 million in China to build the manufacturing factory. "To add more service people and factories in China, to benefit and serve the local customers, which regard China as the important demand market" said by Michael Shafer, Thermo Fisher Scientific's vice-president and general manager in China, from the interview of Beijing BCEIA 2011. To enlarge the market share in China and mergers and acquisitions (M&A) trend are becoming the important strategies for all the global companies.
The development of the Chinese economy is expected to support increasing demand for laboratory analytical instrumentation. China continues to be a major growth driver as government investments to upgrade lab capabilities and capacities remain strong. The leading international companies are likely to increase manufacturing localization, as a result of the enormous human resources involved and the marketing strategy being implemented. The result is that China is becoming the global production base and an important sales market.